Investors - BerGenBio
https://www.bergenbio.com/investors17.03.2022 · Investors. Yearly Reports Annual Report 2020. BerGenBio (OSE:BGBIO) is a clinical-stage biopharmaceutical company developing innovative drugs for aggressive diseases, including immune evasive, drug resistant and metastatic cancers. Our …
Presentations - BerGenBio
www.bergenbio.com › investors › presentationsBerGenBio regularly presents clinical and pre-clinical data at leading scientific congresses and shares company updates at investor relation conferences. Below are presentations given by the company’s senior management and clinical collaborators. Corporate Presentations 2021 2020 2019 2018 2017 Scientific Presentations 2021 2020 2019 2018 2017